VA Awards $2.8M for Reagents to Roche Diagnostics Under Full and Open Competition
Contract Overview
Contract Amount: $2,820,830 ($2.8M)
Contractor: Roche Diagnostics Corporation
Awarding Agency: Department of Veterans Affairs
Start Date: 2023-09-01
End Date: 2027-08-31
Contract Duration: 1,460 days
Daily Burn Rate: $1.9K/day
Competition Type: FULL AND OPEN COMPETITION
Number of Offers Received: 1
Pricing Type: FIRM FIXED PRICE
Sector: Healthcare
Official Description: REAGENTS
Place of Performance
Location: INDIANAPOLIS, MARION County, INDIANA, 46256
State: Indiana Government Spending
Plain-Language Summary
Department of Veterans Affairs obligated $2.8 million to ROCHE DIAGNOSTICS CORPORATION for work described as: REAGENTS Key points: 1. The Department of Veterans Affairs (VA) awarded a $2.8 million contract for reagents. 2. Roche Diagnostics Corporation is the sole awardee, indicating a competitive procurement process. 3. The contract spans four years, suggesting a need for sustained supply. 4. The sector is analytical laboratory instrument manufacturing, crucial for healthcare services.
Value Assessment
Rating: good
The contract's value of $2.8 million over four years appears reasonable for specialized reagents. Benchmarking against similar VA or other federal agency contracts for diagnostic reagents would provide a more precise assessment of value.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The contract was awarded under full and open competition, suggesting multiple vendors had the opportunity to bid. This method typically drives competitive pricing and ensures the government receives fair market value.
Taxpayer Impact: The competitive nature of this award is expected to result in cost savings for taxpayers compared to a sole-source or limited competition scenario.
Public Impact
Ensures continued availability of essential diagnostic reagents for VA healthcare facilities. Supports the operational needs of analytical laboratories within the VA system. Potentially impacts patient care by ensuring timely and accurate diagnostic testing.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Potential for price increases in future contract renewals.
- Dependence on a single supplier for critical reagents.
Positive Signals
- Awarded through full and open competition.
- Long-term contract provides supply stability.
- Firm fixed price contract offers budget certainty.
Sector Analysis
The procurement falls within the analytical laboratory instrument manufacturing sector, which is vital for healthcare diagnostics. Spending in this area is generally consistent with the needs of large healthcare providers like the VA.
Small Business Impact
The data does not indicate whether small businesses were involved in this procurement, either as prime contractors or subcontractors. Further analysis would be needed to determine small business participation.
Oversight & Accountability
The award under full and open competition suggests a robust procurement process. However, ongoing monitoring of contract performance and pricing is essential for accountability.
Related Government Programs
- Analytical Laboratory Instrument Manufacturing
- Department of Veterans Affairs Contracting
- Department of Veterans Affairs Programs
Risk Flags
- Potential for price increases in future contract renewals.
- Dependence on a single supplier for critical reagents.
- Lack of small business participation data.
- Limited visibility into specific reagent types and their criticality.
Tags
analytical-laboratory-instrument-manufac, department-of-veterans-affairs, in, delivery-order, 1m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Veterans Affairs awarded $2.8 million to ROCHE DIAGNOSTICS CORPORATION. REAGENTS
Who is the contractor on this award?
The obligated recipient is ROCHE DIAGNOSTICS CORPORATION.
Which agency awarded this contract?
Awarding agency: Department of Veterans Affairs (Department of Veterans Affairs).
What is the total obligated amount?
The obligated amount is $2.8 million.
What is the period of performance?
Start: 2023-09-01. End: 2027-08-31.
What is the specific type of reagent being procured and its criticality to VA operations?
The specific type of reagent is not detailed in the provided data. However, as it supports analytical laboratory instruments, it is likely critical for diagnostic testing, disease monitoring, and treatment efficacy assessment within the VA healthcare system. Understanding the exact nature of these reagents would clarify their impact on patient care and operational continuity.
Are there any potential supply chain risks associated with Roche Diagnostics Corporation as the sole awardee?
While Roche Diagnostics is a major global player, sole reliance on any single supplier carries inherent supply chain risks. These could include manufacturing disruptions, geopolitical issues, or unforeseen logistical challenges. The VA should have contingency plans in place to mitigate potential shortages or delays.
How does the firm fixed price impact the VA's ability to benefit from potential market price reductions for these reagents?
A firm fixed price contract locks in the price for the duration of the contract, providing budget certainty for the VA. While this protects against price increases, it also means the VA cannot directly benefit if market prices for these reagents were to decrease during the contract period. Any future savings would be realized upon re-competition.
Industry Classification
NAICS: Manufacturing › Navigational, Measuring, Electromedical, and Control Instruments Manufacturing › Analytical Laboratory Instrument Manufacturing
Product/Service Code: INSTRUMENTS AND LABORATORY EQPT
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: SUBJECT TO MULTIPLE AWARD FAIR OPPORTUNITY
Solicitation ID: 36C24723Q0911
Offers Received: 1
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Parent Company: Roche Holding AG
Address: 9115 HAGUE RD, INDIANAPOLIS, IN, 46256
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Foreign Owned, Foreign-Owned and U.S.-Incorporated Business, Manufacturer of Goods, Not Designated a Small Business, Special Designations
Financial Breakdown
Contract Ceiling: $5,966,396
Exercised Options: $2,820,830
Current Obligation: $2,820,830
Contract Characteristics
Commercial Item: COMMERCIAL PRODUCTS/SERVICES
Parent Contract
Parent Award PIID: V797P7347A
IDV Type: FSS
Timeline
Start Date: 2023-09-01
Current End Date: 2027-08-31
Potential End Date: 2028-08-31 00:00:00
Last Modified: 2026-03-24
More Contracts from Roche Diagnostics Corporation
- THE Purpose of This Contract IS to Procure the Procurement of Over the Counter (OTC) Covid-19 Tests — $90.6M (Department of Health and Human Services)
- Cost PER Test — $13.5M (Department of Veterans Affairs)
- CPT — $5.5M (Department of Veterans Affairs)
- Chemistry-Immunochemistry CPR — $4.6M (Department of Veterans Affairs)
- FY22 CPT Chemistry Analyzer — $4.2M (Department of Health and Human Services)
Other Department of Veterans Affairs Contracts
- CCN Region 3 Express Report — $5.2B (Optum Public Sector Solutions, Inc.)
- Express Report for FY22 Region 2 — $5.1B (Optum Public Sector Solutions, Inc.)
- Fiscal Year 2022 Express Report for Region 1 — $4.2B (Optum Public Sector Solutions, Inc.)
- Express Report for the Patient Centered Community Care (PC3) Contract — $3.3B (Triwest Healthcare Alliance Corp)
- CCN Region Three FY21 Express Report — $3.1B (Optum Public Sector Solutions, Inc.)